| Financial Year |
March 31 2023 |
| Monetary Funds |
1,040,728,924.69 |
| Held-for-trading Financial Assets |
300,371,095.90 |
| Notes Receivable |
54,358,425.25 |
| Accounts Receivable |
511,839,492.43 |
| Advances to Suppliers |
13,661,460.51 |
| Other Receivables |
30,854,423.68 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
527,194,826.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
107,838,892.28 |
| Total Current Assets |
3,409,885,753.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
24,824,615.57 |
| Fixed Assetes |
1,235,991,917.92 |
| Under-construction Projects |
567,312,056.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
166,418,928.15 |
| R&D expenses |
1,985,115.78 |
| Goodwill |
18,728,450.11 |
| Long-Term Deferred and Prepaid Expenses |
122,686,167.51 |
| Deferred Income Tax Assets |
19,696,702.73 |
| Other Non-Current Assets |
127,191,162.54 |
| Sub-Total of Non-Current Assets |
2,321,222,556.54 |
| Total Assets |
5,731,108,310.46 |
| Short-Term Loans |
201,934,745.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
385,482,110.44 |
| Accounts Payable |
728,737,819.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
101,803,389.87 |
| Taxes Payable |
31,777,706.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
198,464,458.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
44,029,850.44 |
| Other Current Liabilities |
3,824,476.98 |
| Sub-Total of Current Liabilities |
1,725,499,994.70 |
| Long-term Loans |
127,646,274.45 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
474,825.00 |
| Deferred Income Tax Liabilities |
1,477,748.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
166,556,083.27 |
| Total Liabilities |
1,892,056,077.97 |
| Paid-In Capital(Or Share Stock) |
1,123,125,020.00 |
| Capital Surplus |
1,474,731,400.28 |
| Surplus Reserve |
274,440,284.37 |
| LESS:Treasury Stock |
156,751,234.00 |
| Undistributed Profits |
1,123,506,761.84 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,839,052,232.49 |
| Owner's Equity（Stockholder's Equity） |
3,839,052,232.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,731,108,310.46 |
